Monitoring
Follow-up of patients is recommended for at least 1 month after symptoms resolve in order to monitor for possible development of severe symptom onset or chronic sequelae, such as ocular complications (specifically retinitis) or neurological complications.
Use of this content is subject to our disclaimer